Similarly, in CRC, IGF2BP2 binds to YAP mRNA to promote its translation, and verteporfin reduces the number of cancer-associated fibroblasts, inhibiting angiogenesis and tumor progression [107–109]. The gene discussed is IGF2BP2; the disease is neoplasm.